Innovation

Can Human Factors Revolutionize Acute Care Quality and Safety?
Digital Health Can Human Factors Revolutionize Acute Care Quality and Safety?

In the ever-evolving landscape of health care, one emerging initiative stands out for its groundbreaking potential to enhance patient safety and care quality in acute medical settings. A pioneering academic practice partnership (APP) between William Osler Health System (Osler) and the University of

Federal Court Overturns FDA Regulation on Lab Developed Tests
Regulatory & Compliance Federal Court Overturns FDA Regulation on Lab Developed Tests

In a landmark ruling, a Texas federal court recently overturned the Food and Drug Administration’s (FDA) regulation of laboratory-developed tests (LDTs) as medical devices. This decision, made by Judge Sean Jordan of the U.S. District Court for the Eastern District of Texas, vacates the FDA’s final

AI and Precision Oncology: How Companion Diagnostics Save Lives
Imaging & Diagnostics AI and Precision Oncology: How Companion Diagnostics Save Lives

Companion diagnostics have revolutionized the field of precision oncology by enabling the identification of patients who will benefit most from targeted therapies. Focusing on the genetic and molecular characteristics of an individual's cancer, these diagnostics have significantly improved

Navigating AI in Healthcare: Balancing Innovation and Regulation
Digital Health Navigating AI in Healthcare: Balancing Innovation and Regulation

Experts across technology developers, EHR vendors, and hospitals are grappling with the governance of AI as its algorithms grow increasingly pervasive in patient care operations and delivery. Concerns are rising with the growing adoption of AI and limited comprehensive supervision from the federal

How Can AI Transform E-Prescribing Efficiency in Hospice Care?
Digital Health How Can AI Transform E-Prescribing Efficiency in Hospice Care?

The integration of artificial intelligence (AI) in the healthcare sector is revolutionizing various processes, including e-prescribing in hospice care. AI's ability to enhance accuracy and reduce prescription time is addressing long-standing challenges in the industry. The shift to AI

Is J&J's $55 Billion U.S. Investment Changing Pharmaceutical Manufacturing?
Regulatory & Compliance Is J&J's $55 Billion U.S. Investment Changing Pharmaceutical Manufacturing?

Johnson & Johnson’s commitment to investing $55 billion in U.S. manufacturing, research, and development over the next four years marks a significant expansion for the renowned pharmaceutical company. Announced by CEO Joaquin Duato on March 21, this ambitious initiative is intended to bolster t

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later